Long-term efficacy, safety and PK data of TH1902 (sudocetaxel zendusortide) in solid tumors: A novel SORT1-targeting peptide-drug-conjugate (PDC)
Wednesday, June 19, 2024
Dr. Minal Barve
Click above link to view abstract.
![ASCO 2024 Poster for Trial 21-46](https://marycrowley.org/wp-content/uploads/2024/06/Poster-2-scaled.jpg)
ASCO 2024 Poster for Trial 21-46